open access

Vol 70, No 6 (2012)
Original articles
Published online: 2012-06-20
Submitted: 2012-12-28
Get Citation

Correlation of the myocardial performance index with plasma B−type natriuretic peptide levels in type 2 diabetes mellitus and impaired glucose tolerance

Murat Turfan, Ahmet Akyel, H. Ata Bolayir, M. Akif Vatankulu, Müjde Aktürk, Ilhan Yetkin, Bülent Boyaci
Kardiol Pol 2012;70(6):556-562.

open access

Vol 70, No 6 (2012)
Original articles
Published online: 2012-06-20
Submitted: 2012-12-28

Abstract

Background and aim: In this study, we aimed to evaluate myocardial functions in patients with diabetes mellitus (DM) and impaired glucose tolerance (IGT). We also aimed to investigate the relationship between B-type natriuretic peptide (BNP) levels and myocardial performance index (Tei index) in these patients.
Methods: A total of 38 patients with DM, 34 patients with IGT, and 40 healthy volunteers were recruited to the study. Basal clinical and laboratory findings were recorded. BNP levels of all individuals were measured. Both conventional transthoracic and tissue Doppler echocardiogaphy were performed to all study participants.
Results: B-type natriuretic peptide levels of the diabetic group were greater than in patients with IGT and the control group. BNP levels of the IGT group were also higher than the control group. Myocardial performance index values, measured by both the conventional method and tissue Doppler echocardiography, were significantly higher in the diabetic group than in the control group. There was a significant relationship between myocardial performance index and BNP levels.
Conclusions: Myocardial functions are disturbed in patients with DM and also in patients with IGT. BNP and myocardial performance index can be used in diabetic patients and in patients with IGT to define myocardial dysfunction.

Abstract

Background and aim: In this study, we aimed to evaluate myocardial functions in patients with diabetes mellitus (DM) and impaired glucose tolerance (IGT). We also aimed to investigate the relationship between B-type natriuretic peptide (BNP) levels and myocardial performance index (Tei index) in these patients.
Methods: A total of 38 patients with DM, 34 patients with IGT, and 40 healthy volunteers were recruited to the study. Basal clinical and laboratory findings were recorded. BNP levels of all individuals were measured. Both conventional transthoracic and tissue Doppler echocardiogaphy were performed to all study participants.
Results: B-type natriuretic peptide levels of the diabetic group were greater than in patients with IGT and the control group. BNP levels of the IGT group were also higher than the control group. Myocardial performance index values, measured by both the conventional method and tissue Doppler echocardiography, were significantly higher in the diabetic group than in the control group. There was a significant relationship between myocardial performance index and BNP levels.
Conclusions: Myocardial functions are disturbed in patients with DM and also in patients with IGT. BNP and myocardial performance index can be used in diabetic patients and in patients with IGT to define myocardial dysfunction.
Get Citation

Keywords

diabetes mellitus; B-type natriuretic peptide; myocardial performance index; glucose tolerance

About this article
Title

Correlation of the myocardial performance index with plasma B−type natriuretic peptide levels in type 2 diabetes mellitus and impaired glucose tolerance

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Vol 70, No 6 (2012)

Pages

556-562

Published online

2012-06-20

Bibliographic record

Kardiol Pol 2012;70(6):556-562.

Keywords

diabetes mellitus
B-type natriuretic peptide
myocardial performance index
glucose tolerance

Authors

Murat Turfan
Ahmet Akyel
H. Ata Bolayir
M. Akif Vatankulu
Müjde Aktürk
Ilhan Yetkin
Bülent Boyaci

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., Świętokrzyska 73 street, 80–180 Gdańsk, Poland

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail: viamedica@viamedica.pl